A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS, a ...
Our top 10 ALS news stories of 2025 feature actor Eric Dane’s advocacy and major research milestones in the field.
QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of ...
The FDA has cleared the initiation of a pivotal Phase 3 trial testing pridopidine in people with early, rapidly progressive ...
Historically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline in neurological function that ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Researchers have found that patients with amyotrophic lateral sclerosis have ...
In this photo provided by I AM ALS, Dan Tate, right, delivers a printed petition from ALS patients and advocates to Dr. Peter Marks, left, director of the Food and Drug Administration's center for ...
The annual Plunge for Pete, a mass dip into the icy Atlantic to raise money for ALS patients, is aimed<a ...
ALS is a debilitating paralytic disease characterized as the death of upper and lower motor neurons. Fortunately, ALS is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback